We are international
Donate
• treatment options TEXT SIZE   
novel therapies    back

Dr. Moreau - A Phase 3 Prospective Randomized International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib In Patients with Relapsed Multiple Myeloma
Philippe Moreau, MD
University Hospital
Nantes, France
12.02.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles